Physician

Tyler Howard Buckley, M.D.

According to 2025 Medicare claims, Tyler Buckley, M.D. (NPI: 1407299522) practices medical oncology in the Lewiston, ID-WA market, with the plurality of this provider's patient population coming from Nez Perce, ID. This provider's primary affiliated billing organization is ST JOSEPH HOSPITAL LLC (NPI: 1205368404; TIN: 36-4851166) and primary practice location at 83501-2431. Buckley is affiliated with the Kootenai Accountable Care, LLC (ACO ID: A3621), Caravan Collaborative Pathways (ACO ID: A4604), AdvantagePoint Health Alliance - Northwest, LLC (ACO ID: A5025), Caravan Health ACO 50 LLC (ACO ID: A5160), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Buckley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 361 traditional Medicare patients, billed 1,024 HCPCS/CPT codes, and received $93,319 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,185 prescription claims across 210 beneficiaries totaling $2,607,653 in drug costs, led by Revlimid (Lenalidomide). DME data shows 60 claims. Open Payments data shows 1 records totaling $21. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $14,559 to $93,319. Similarly, Part D prescription costs have moved sharply higher in recent years, from $9,986 to $2,607,653. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$52K$105K2019 Medicare payment: $14,559 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $67,263 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $28,002 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $54,378 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $104,783 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $93,319 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
201994185$14,559
20202981,029$67,263
2021184391$28,002
2022214569$54,378
20233471,145$104,783
20243611,024$93,319

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.3M$2.6M2015 Drug cost: $9,986 (USD; Tot_Drug_Cst)2016 Drug cost: $4,044 (USD; Tot_Drug_Cst)2017 Drug cost: $42,780 (USD; Tot_Drug_Cst)2018 Drug cost: $72,253 (USD; Tot_Drug_Cst)2019 Drug cost: $145,924 (USD; Tot_Drug_Cst)2020 Drug cost: $914,963 (USD; Tot_Drug_Cst)2021 Drug cost: $898,591 (USD; Tot_Drug_Cst)2022 Drug cost: $937,754 (USD; Tot_Drug_Cst)2023 Drug cost: $2,481,295 (USD; Tot_Drug_Cst)2024 Drug cost: $2,607,653 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151558$9,986
20162952$4,044
20172866$42,780
20181756$72,253
201950165$145,924
2020146720$914,963
2021108495$898,591
2022159819$937,754
20231991,123$2,481,295
20242101,185$2,607,653

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.6K$7.2K2020 Medicare payment: $1,922 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,301 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $7,245 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,627 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R13$1,922
2021N/RN/RN/R
2022N/R40$1,301
2023N/R63$7,245
2024N/R60$1,627

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more6666$132
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more180556$104
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more4949$97
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more168255$68
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5871$43

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide24672$461,204
LenalidomideLenalidomide381,057$453,010
JakafiRuxolitinib Phosphate361,080$299,984
ImbruvicaIbrutinib13364$207,833
XtandiEnzalutamide12360$178,555

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R30$1,100
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R30$527

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$21Coherus Biosciences Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

Explore More Providers

FAQ

What Medicare data is available for Tyler Howard Buckley, M.D.?

Tedicare shows public-source Medicare data for Tyler Howard Buckley, M.D. (NPI 1407299522), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tyler Howard Buckley, M.D. have ACO affiliation data?

Tyler Howard Buckley, M.D. is shown with ACO affiliation data for Kootenai Accountable Care, LLC (MSSP, ACO ID A3621), Caravan Collaborative Pathways (MSSP, ACO ID A4604), AdvantagePoint Health Alliance - Northwest, LLC (MSSP, ACO ID A5025), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Tyler Howard Buckley, M.D.?

Tyler Howard Buckley, M.D. is linked to ST JOSEPH HOSPITAL LLC (billing NPI 1205368404) in the available physician profile data.

Does Tyler Howard Buckley, M.D. have Open Payments data?

Tyler Howard Buckley, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.